This site uses third party services that need your consent. Learn more

Skip to content


We want to give you the tools to be able to learn about MPS, Fabry and related diseases in order for children with the condition to receive a faster diagnosis.

Learn about Fabry disease

Discover the newly-developed Fabry disease online learning platform. Written and developed by Professor Derralynn Hughes, the platform offers professionals in-depth knowledge of Fabry disease.

Funding opportunities


Our Clinical Scientific Advisory Committee (CSAC) consists of members of our Board of Trustees and the Society’s Patient Advocacy team who will consider research applications each year.

Memorial Fund

As part of the MPS Society’s 40th anniversary, we launched the Christine Lavery Memorial Fund for summer vacation studentships in memory of our founder to provide funding for two studentships for undergraduates.

Research grants

The MPS Society is inviting applications for research grants in MPS, Fabry and related diseases. We are currently inviting research applications on the theme of psychological wellbeing.

Find out about the conditions

We’ve got a wealth of information about each of our conditions.

What are Mucopolysaccharide (MPS) diseases?

Mucopolysaccharide (MPS) diseases are a family of rare, life limiting lysosomal storage disorders that can affect both children and adults.

What is Fabry?

Fabry disease is closely related to mucopolysaccharidoses and is one of the lysosomal storage diseases.

Related diseases

The MPS Society supports 25 MPS and related diseases including the Mucolipidoses, other ‘storage diseases’ and the following conditions which are similar to Mucopolysaccharide Diseases.

Spot the signs

The MPS Society is committed to bringing about change in the diagnostic journey of children affected by these rare conditions.

The Think Rare, Think MPS campaign supports earlier recognition of the signs and symptoms of MPS diseases by engaging with and educating the healthcare professionals most likely to see a patient with MPS in the early stages of the disease. #Spotthesigns

To find out more about our Think Rare, Think MPS campaign, please read our blog post below. 

Resources for professionals